Share jump for ArQule on news it could revive lung cancer drug – MedCity News

by lowes1 on September 27, 2013

Share jump for ArQule on news it could revive lung cancer drug
MedCity News
(Reuters) – ArQule Inc shares jumped 19 percent on hopes that additional data from a discontinued trial could revive its experimental drug, tivantinib, as a treatment for lung cancer. Last October, ArQule and Daiichi Sankyo Inc stopped a late-stage

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: